No Picture
Los Angeles Biotech News

Roche China CEO preps for a move to Merck KGaA while US Merck adds to C-suite; Succession plan finalized for EVPs retiring from Sanofi

Hong Chow → Beginning Oct. 1, Roche China CEO Hong Chow will be head of China & international for Merck KGaA’s healthcare business, a position that also encompasses Japan, Europe, Latin America, Asia-Pacific, the Middle East, Africa and Russia. The… […]

No Picture
Los Angeles Biotech News

CytRx Announces Director Election Results from 2021 Annual Meeting of Stockholders

LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (OTCQB: CYTR) ("CytRx" or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today announced t… […]

No Picture
Los Angeles Biotech News

Takeda doubles down at California site as it looks to grow rare disease manufacturing base

Japanese drugmaker Takeda is looking to ramp up the efficiency of its rare diseases manufacturing, which includes programs for hemophilia and Von Willebrand disease. It will turn to a California location it’s familiar with to bring its operations into … […]

No Picture
Los Angeles Biotech News

CytRx Highlights Preliminary Results of Cohort C of QUILT 88, a Phase 2 Pancreatic Cancer Trial That Includes Aldoxorubicin, Expected to be Released in Q1 2022

LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (OTCQB: CYTR) ("CytRx" or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today highlighted… […]

No Picture
Los Angeles Biotech News

AstraZeneca and Amgen quietly admit tezepelumab defeat as the Dupixent challenger heads to FDA

AstraZeneca and Amgen have blockbuster ambitions for their tezepelumab antibody, aiming to challenge the Regeneron and Sanofi giant Dupixent in asthma and related respiratory maladies. But as part of its second quarter update Thursday morning, the big … […]